James Eadie
Angel · Minnesota
Board director at 4 startups that filed Form D raises since late 2024, mostly in Minnesota.
- Stages
- Series A to Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Aug 2025
Focus
HealthcareBiotech & PharmaRecent portfolio activity
Sources
- SEC Form D: EndogenexFeb 24, 2023
- SEC Form D: GENEOS TherapeuticsApr 13, 2023
- SEC Form D: Reprieve CardiovascularNov 20, 2023
- SEC Form D: CryOSAAug 1, 2025
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.